Sumitomo Pharma Co's dividends per share for the
three
months ended in Dec. 2023 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.05. Its Dividend Payout Ratio for the
three
months ended in Dec. 2023 was 0.00. As of today, Sumitomo Pharma Co's Dividend Yield % is 1.80%.
During the past 12 months, Sumitomo Pharma Co's average Dividends Per Share Growth Rate was -75.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -9.10% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 2.20% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 4.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sumitomo Pharma Co was 53.30% per year. The lowest was -9.10% per year. And the median was 15.90% per year.
For more information regarding to dividend, please check our Dividend Page.
Sumitomo Pharma Co Dividends per Share Historical Data
The historical data trend for Sumitomo Pharma Co's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sumitomo Pharma Co's Dividends per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sumitomo Pharma Co's Dividend Yield % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sumitomo Pharma Co's Dividend Yield % falls into.
Sumitomo Pharma Co Dividends per Share Calculation
Dividends paid to per common share.
Sumitomo Pharma Co (OTCPK:DNPUF) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Sumitomo Pharma Co's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Sumitomo Pharma Co was 1.00. The lowest was 0.13. And the median was 0.23.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
During the past 13 years, the highest Dividend Yield of Sumitomo Pharma Co was 4.47%. The lowest was 0.47%. And the median was 1.38%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sumitomo Pharma Co Dividends per Share Related Terms
Thank you for viewing the detailed overview of Sumitomo Pharma Co's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DNPUF has been successfully added to your 